首页 > 资讯
Ad hoc announcement pursuant to Art. 53 LR
Baar (Switzerland), 21 January 2025
Based on preliminary unaudited figures, Ascom reports for fiscal year 2024 a revenue of CHF 286.7 million, which is a decline of 1.6% at constant currencies, and an EBITDA margin of around 7.5%.
In a continuing challenging market environment, Ascom generated net revenue of CHF 286.7 million for fiscal year 2024 (2023: CHF 297.3 million), which reflects a decline of 1.6% at constant currencies and of 3.6% at actual currencies compared to the previous year, based on preliminary unaudited figures.
Revenue development showed a mixed picture. The best performance was achieved in the key markets Nordics, DACH, the Netherlands, and Italy, while UK and the OEM business underperformed due to lower market traction than expected and project delays in the last quarter of 2024. The especially disappointing results in USA & Canada and France & Spain have also triggered a management change and both regions have new Managing Directors as of January 2025.
Incoming orders came to CHF 307.4 million (2023: CHF 318.6 million), representing a decline of 1.5% at constant currencies and of 3.5% at actual currencies. The order backlog stood at CHF 301.5 million as of year-end 2024 (31.12.2023: CHF 276.4 million).
Due to the lower revenue and higher investments in Research & Development (R&D) as well as in Marketing & Sales, Ascom achieved for fiscal year 2024 a lower EBITDA margin of around 7.5% (2023: EBITDA margin of 10.1%). Considering the lower EBITDA and higher costs for depreciation and amortization due to investments in R&D and ERP (Enterprise Resource Planning), the 2024 Group profit will be substantially lower than in the previous year and is expected to be in the range of CHF 3 to 4 million, also impacted by a non-cash one-off adjustment of about CHF 2 million.
Ascom continues to have a solid balance sheet with a net cash position of CHF 18.6 million as of year-end 2024 (31.12.2023: CHF 24.7 million) and an equity ratio of around 39%.
Annual Media Conference 2025
The full details of the financial statements and the 2024 Annual Report, including dividend proposal and 2025 guidance, will be published on 12 March 2025.
Contact
Daniel Lack
Senior VP Legal & Communications / IR
+41 41 544 78 10
daniel.lack@ascom.com
Investor@ascom.com
- 搜索
-
- 04-11中医药专家于晓津携御君方专家团队出席2025年动脉粥样硬化健康论坛,以临床实证共话中医药科学价值
- 04-11易思脑与汇聚英才成功举行神经回馈训练国际认证助学中心挂牌仪式
- 04-11福城焕新颜 古韵谱华章——金融活水润泽郴州乡村振兴新图景
- 04-11加密货币交易量攀新高 香港券商转型交易量突破百亿居龙头
- 04-11保研录战略收购清华系创业团队“保研印象”,加速清北资源整合与技术创新
- 04-11杜丁副主任医师携御君方全国专家团队亮相2025年动脉粥样硬化健康论坛
- 04-11ProstaVive Reviews (BREAKING REPORT): Must-Read Warnings, Ingredients, Benefits & Real Results U
- 04-11ProstaVive: We Tested It for 90 Days—Our Full Month-by-Month Review and the Shocking Truth About Lon
- 04-11AquaSculpt Reviews (BREAKING): 27,000 CONSUMERS Tracked Over 90 Days—We Finally Have the Answer
- 04-11Bioventra Inc. Reports Surge in Sales of Flagship Wellness Products Mitolyn® and PrimeBiome® in Q1 2